0001209191-21-071123.txt : 20211223
0001209191-21-071123.hdr.sgml : 20211223
20211223173210
ACCESSION NUMBER: 0001209191-21-071123
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211221
FILED AS OF DATE: 20211223
DATE AS OF CHANGE: 20211223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Evanson Jeff
CENTRAL INDEX KEY: 0001760511
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37759
FILM NUMBER: 211518240
MAIL ADDRESS:
STREET 1: C/O ONCOBIOLOGICS, INC.
STREET 2: 7 CLARKE DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Outlook Therapeutics, Inc.
CENTRAL INDEX KEY: 0001649989
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 383982704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 485 ROUTE 1 SOUTH
STREET 2: BUILDING F, SUITE 320
CITY: ISELIN
STATE: NJ
ZIP: 08830
BUSINESS PHONE: 6096193990
MAIL ADDRESS:
STREET 1: 485 ROUTE 1 SOUTH
STREET 2: BUILDING F, SUITE 320
CITY: ISELIN
STATE: NJ
ZIP: 08830
FORMER COMPANY:
FORMER CONFORMED NAME: Oncobiologics, Inc.
DATE OF NAME CHANGE: 20150804
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-12-21
0
0001649989
Outlook Therapeutics, Inc.
OTLK
0001760511
Evanson Jeff
C/O OUTLOOK THERAPEUTICS, INC.
485 ROUTE 1 SOUTH, BLDG F, SUITE 320
ISELIN
NJ
08830
0
1
0
0
Chief Commercial Officer
Stock Option (Right to Buy)
1.44
2021-12-21
4
A
0
800000
0.00
A
2031-12-21
Common Stock
800000
800000
D
25% of the shares subject to the option shall vest on December 21, 2022, with the remaining shares vesting in equal monthly installments over the following three years thereafter, subject to the Reporting Person's continuous service with the Issuer on each such date. The option is also subject to acceleration under certain circumstances.
/s/ Lawrence Kenyon, Attorney-in-Fact
2021-12-23